NTLA Stock-Based Compensation
Intellia Therapeutics Inc · Stock-Based Compensation
NTLA Stock-Based Compensation
Latest reported$141.95Mperiod ending
NTLA Stock-Based Comp ($462.00K → $141.95M)
Annual stock-based compensation
High-resolution chart · PNG
NTLA stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 154,273,000 | |
| 154,273,000 | |
| 134,050,000 | |
| 91,400,000 | |
| 47,009,000 | |
| 19,903,000 | |
| 15,091,000 | |
| 17,046,000 | |
| 15,322,000 | |
| 6,715,000 | |
| 1,308,000 | |
| 462,000 |